Cargando…
Metabolic gene alterations impact the clinical aggressiveness and drug responses of 32 human cancers
Malignant cells reconfigure their metabolism to support oncogenic processes such as accelerated growth and proliferation. The mechanisms by which this occurs likely involve alterations to genes that encode metabolic enzymes. Here, using genomics data for 10,528 tumours of 32 different cancer types,...
Autores principales: | Sinkala, Musalula, Mulder, Nicola, Patrick Martin, Darren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856368/ https://www.ncbi.nlm.nih.gov/pubmed/31754644 http://dx.doi.org/10.1038/s42003-019-0666-1 |
Ejemplares similares
-
Integrated molecular characterisation of the MAPK pathways in human cancers reveals pharmacologically vulnerable mutations and gene dependencies
por: Sinkala, Musalula, et al.
Publicado: (2021) -
Integrative landscape of dysregulated signaling pathways of clinically distinct pancreatic cancer subtypes
por: Sinkala, Musalula, et al.
Publicado: (2018) -
Machine Learning and Network Analyses Reveal Disease Subtypes of Pancreatic Cancer and their Molecular Characteristics
por: Sinkala, Musalula, et al.
Publicado: (2020) -
Mutational landscape of cancer-driver genes across human cancers
por: Sinkala, Musalula
Publicado: (2023) -
A genome-wide association study identifies distinct variants associated with pulmonary function among European and African ancestries from the UK Biobank
por: Sinkala, Musalula, et al.
Publicado: (2023)